- DNA methylation-associated colonic mucosal immune and defense responses in treatment-naive pediatric ulcerative colitis2014 | Second Faculty of Medicine
- Sequential Therapy for Helicobacter pylori Infection in Treatment-naive Children2016 | Faculty of Medicine in Pilsen
- Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Nivolumab plus Cabozantinib Joins Immune Checkpoint Inhibition Combination Therapies for Treatment-naïve Metastatic Clear-Cell Renal Cell Carcinoma2021 | Faculty of Medicine in Pilsen
- The 2021 Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Immune Checkpoint Inhibitor-based Combination Therapies for Treatment-naive Metastatic Clear-cell Renal Cell Carcinoma Are Standard of Care2021 | Faculty of Medicine in Pilsen
- Microbiota Separation and C-reactive Protein Elevation in Treatment-naive Pediatric Granulomatous Crohn Disease2012 | Second Faculty of Medicine
- Persistence with first line anticholinergic medication in treatment-naive overactive bladder patients2014 | Publication without faculty affiliation
- Zanubrutinib monotherapy for patients with treatment-naïve chronic lymphocytic leukemia and 17p deletion2021 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- Efficacy and safety of peginterferon alpha-2a (40KD) plus ribavirin in treatment-naive chronic hepatitis C patients in Central and Eastern Europe2011 | First Faculty of Medicine
- The Assessment of Plasma Fatty Acid Profiles in Newly Diagnosed Treatment-Naïve Paediatric Crohn's Disease2021 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Glecaprevir/pibrentasvir for 8 weeks in treatment-naive patients with chronic HCV genotypes 1-6 and compensated cirrhosis: The EXPEDITION-8 trial2020 | First Faculty of Medicine
- Metreleptin Robustly Increases Resting-state Brain Connectivity in Treatment-naïve Female Patients With Lipodystrophy2023 | First Faculty of Medicine
- Final report of University Hospital Hradec Kralove to the clinical trial protocol no. PCYC-1130-CAPublication without faculty affiliation
- Antiviral activity and safety of 12 weeks of or treatment with ACH-126 (BETA-L-FD4C) in treatment-naive patienst with chronic HBV infection2003 | Faculty of Medicine in Hradec Králové
- Characterization of Early Disease Status in Treatment-Naive Male Paediatric Patients with Fabry Disease Enrolled in a Randomized Clinical Trial2015 | First Faculty of Medicine
- Glecaprevir/pibrentasvir for 8 weeks in treatment-naïve patients with chronic HCV genotypes 1-6 and compensated cirrhosis: The EXPEDITION-8 trialPublication without faculty affiliation
- Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease in Patients Naive to or Who Have Failed Tumor Necrosis Factor Antagonist Therapy2017 | First Faculty of Medicine
- Preservative-free tafluprost in the treatment of naive patients with glaucoma and ocular hypertension2013 | Publication without faculty affiliation
- Incidence of adverse events after loading phase of the brolucizumab therapy of neovascular AMD: Real-life evidence in the Czech Republic2023 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Third Faculty of Medicine, Central Library of Charles University
- Interleukin 35 Synovial Fluid Levels Are Associated with Disease Activity of Rheumatoid Arthritis2015 | First Faculty of Medicine
- Research Report University Hospital of the clinical trial 1200.55Publication without faculty affiliation
- Report of University Hospital Hradec Králové to the clinical trial protocol No. AI452-020-0030Publication without faculty affiliation
- Teriparatide Reduces Bone Microdamage Accumulation in Postmenopausal Women Previously Treated with Alendronate2009 | First Faculty of Medicine
- Teriparatide Reduces Bone Microdamage Accumulation in Postmenopausal Women Previously Treated with Alendronate2009 | Publication without faculty affiliation
- Histomorphometric changes by teriparatide in alendronate-pretreated women with osteoporosis2010 | First Faculty of Medicine
- Changes in the immune system of untreated patients with chronic lymphocytic leukaemia - Part 1: Adaptive immunity2021 | Faculty of Medicine in Hradec Králové
- Chemoimmunotherapy with O-FC previously untreated patients with chronic lymphocytic leukemia2011 | Faculty of Medicine in Hradec Králové
- Single-agent ibrutinib in RESONATE-2TM and RESONATETM versus treatments in the real-world PHEDRA databases for patients with chronic lymphocytic leukemia2019 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- New agent to enhance targeted therapy of metastatic HER2+ breast cancer - pertuzumab2013 | First Faculty of Medicine
- Riociguat in patients with chronic thromboembolic pulmonary hypertension: results from an early access study2017 | Publication without faculty affiliation
- Expression of TIM-3 on Plasmacytoid Dendritic Cells as a Predictive Biomarker of Decline in HIV-1 RNA Level during ART2018 | First Faculty of Medicine, Faculty of Science, Third Faculty of Medicine